Parental age and birth defect risk by disease type
Shared by user

This is a copy of a chat between Claude and user. Content may include unverified or unsafe content that do not represent the views of Anthropic. Shared snapshot may contain attachments and data not displayed here.

You said: What is the paternal vs maternal contribution to birth defects and congenital diseases from age 20s vs 50s, each controlled for paternal and maternal age.

What is the paternal vs maternal contribution to birth defects and congenital diseases from age 20s vs 50s, each controlled for paternal and maternal age. use absolute risk numbers. separate the diseases by reproductively continuable (like ADHD or bipolar) vs reproductively uncontinuable (like stillbirth, miscarriage, or down syndrome) show the results in a easy to read compact table

Apr 29

Claude responded: Here's a synthesized view from the epidemiological literature.

Searched the web

Here's a synthesized view from the epidemiological literature. Important upfront caveats: maternal age 50 conceptions are extremely rare without donor eggs (which strips the chromosomal-error contribution), and "controlled for" the other parent means the effect is independent of that parent's age but residual confounding (smoking, BMI, parity, IVF) is hard to fully eliminate.

Reproductively uncontinuable outcomes

(pregnancy loss, early death, or conditions that preclude reproduction)

OutcomeMother 20sMother 50s†Father 20sFather 50s
Clinically recognized miscarriage~10% (low at 25–29)~50–75%+ (own eggs)reference~14% (≈1.4× of 20s)
Stillbirth (per 1,000 births)~4~8–10~4–5~5–6
Down syndrome (live birth)1 in 1,250 (0.08%) at 25~1 in 25–30 (3–4%) at 45+~1 in 1,250~1 in 1,100 (negligible independent effect)
Trisomy 13 / 18<1 in 5,000~1 in 200–500minimalminimal
Any chromosomal abnormality at birth~0.2–0.3%~5%+~0.2–0.3%small independent rise

Reproductively continuable outcomes

(child typically survives to adulthood and can reproduce)

OutcomeMother 20sMother 50s†Father 20sFather 50s
Autism spectrum disorder~1.5%~2.0–2.5%~1.5%~2.5–2.8% (≈1.7–2.2× of 20s)
Schizophrenia~0.5–0.7%mild / inconsistent~0.5% (1 in 198)~1.6% (1 in 61)
Bipolar disorder~1.0%~1.0% (no clear effect)~1.0%~2.5–2.8% (≈2.8× of 30–34)
ADHD (lifetime)~9%~9%~9%weak/mixed when controlled for maternal age
Congenital heart defects (any)~9 / 1,000~10 / 1,000~9 / 1,000~11–12 / 1,000 (OR ~1.27 at ≥40)
Achondroplasiabaseline (~1 / 25,000)baseline~1 / 100,000~1 / 8,000 (≈12×)
Apert syndrome~1 / 50,000~1 / 50,000~1 / 100,000~1 / 25,000–30,000
Childhood acute lymphoblastic leukemia~1 / 2,000 by age 15~1 / 2,000~1 / 2,000~1 / 1,400 (modest rise)

†Mother-50s natural conception is rare; numbers above 45 are extrapolated and assume own eggs. Donor-egg pregnancies at 50 carry chromosomal risk of the donor's age, not the gestational mother's.

How to read the contributions

  • Maternal age dominates the uncontinuable column — almost entirely driven by oocyte aging causing aneuploidy (Down, Edwards, Patau, miscarriage of chromosomally abnormal embryos).
  • Paternal age dominates the continuable column — driven by accumulating de novo point mutations in spermatogonial stem cells (~2 new mutations/year of paternal age), producing the autism / schizophrenia / bipolar / FGFR-disorder pattern.
  • Absolute paternal-age risk is small for any one disease but the aggregate across all neurodevelopmental and de novo conditions adds meaningfully — roughly an additional 1–2 percentage points of total offspring risk going from father 25 → 50.
  • For most outcomes, both parents' ages add risk roughly independently rather than multiplicatively, so a 50-year-old father with a 30-year-old mother carries much less combined risk than a 50/50 couple.

Primary sources: Magnus et al. (BMJ 2019, Norway miscarriage register, n=421k); Morris et al. (Down syndrome by maternal age); Malaspina et al. (Jerusalem schizophrenia cohort); de Kluiver meta-analysis (paternal age & psychiatric disorders); du Fossé et al. (Hum Reprod Update 2020, paternal age miscarriage meta-analysis); Goriely & Wilkie (FGFR2/FGFR3 PAE disorders).